HLA Symposium - in health and disease, 16th to 17th of June 2020, Zürich, Switzerland
We are pleased to announce our international symposium on the topic HLA - in health and disease, which will take place on June 16-17, 2020 at the University Hospital Zurich. We will bring together internationally renowned experts and young scientists from this highly interesting field of research. The aim is to exchange current research results on the topic, learn from outstanding scientists and initiate new collaborations. And we want to invite you to be part of it. Please find below further information. Registration is mandatory, but free of charge. Places are limited.
When: Two-day event on the 16th and 17th of June 2020
Where: Hörsaal Nord1, Frauenklinikstrasse 24, 8091 Zürich, University Hospital Zurich
Who: Interested persons of academic institutions can register at the end of the page
Costs: No costs - the symposium is free of charge. However, places are limited and will be allocated upon receipt of registration. First comes, first serves.
Program: We are delighted that several national and international experts followed our invitation. You will find a list of confirmed speakers below. The program will soon be uploaded.
Poster Session: We will have two poster sessions. Please send your abstract submission until 24th of April 2020. It is possible to register and state that you will hand in an abstract later. The best poster will be awarded with a poster prize.
Short oral presentations: The program will also include some short presentations by Young Researchers. We will select interested young researchers as speakers from the abstract. Please follow the instruction in the registration field.
Organizers:
Hans-Georg Rammensee - Department of Immunology, Institute of Cell Biology, University of Tübingen, Germany &
Roland Martin - Neuroimmunology and MS Research, Dep. of Neurology, University of Zürich, Switzerland
When: Two-day event on the 16th and 17th of June 2020
Where: Hörsaal Nord1, Frauenklinikstrasse 24, 8091 Zürich, University Hospital Zurich
Who: Interested persons of academic institutions can register at the end of the page
Costs: No costs - the symposium is free of charge. However, places are limited and will be allocated upon receipt of registration. First comes, first serves.
Program: We are delighted that several national and international experts followed our invitation. You will find a list of confirmed speakers below. The program will soon be uploaded.
Poster Session: We will have two poster sessions. Please send your abstract submission until 24th of April 2020. It is possible to register and state that you will hand in an abstract later. The best poster will be awarded with a poster prize.
Short oral presentations: The program will also include some short presentations by Young Researchers. We will select interested young researchers as speakers from the abstract. Please follow the instruction in the registration field.
Organizers:
Hans-Georg Rammensee - Department of Immunology, Institute of Cell Biology, University of Tübingen, Germany &
Roland Martin - Neuroimmunology and MS Research, Dep. of Neurology, University of Zürich, Switzerland
Confirmed speaker (alphabetical order)
Michael Birnbaum - Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Boston, USA
Søren Buus - Dept. of Immunology and Microbiology, University of Copenhagen, Denmark
Mary Carrington - Laboratory of Integrative Cancer Immunology, Center for Cancer Research, NIH, Frederick, USA §
Lars Fugger - Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK
Antonio Lanzavecchia - Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland
Frank Momburg - Translational Immunology, German Cancer Research Center, Heidelberg, Germany
Tomas Olsson - Department of Neurology, Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden
Jamie Rossjohn - Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
Federica Sallusto - Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera italiana, Bellinzona, Switzerland
Pere Santamaria - Department of Microbiology, Immunology & Infectious Diseases, University of Calgary, Canada
Alessandro Sette - Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, USA
Craig Slingluff - University of Virginia School of Medicine, Charlottesville, VA, USA
Ludvig Sollid - Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway (final confirmation pending)
Stefan Stevanović - Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany
Kai Wucherpfennig - Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, USA
We are also happy to announce that we will dedicate the session “Tumor Immunology” to Stefan Stevanović on his 60th birthday to honor his achievements in this field.
Søren Buus - Dept. of Immunology and Microbiology, University of Copenhagen, Denmark
Mary Carrington - Laboratory of Integrative Cancer Immunology, Center for Cancer Research, NIH, Frederick, USA §
Lars Fugger - Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK
Antonio Lanzavecchia - Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland
Frank Momburg - Translational Immunology, German Cancer Research Center, Heidelberg, Germany
Tomas Olsson - Department of Neurology, Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden
Jamie Rossjohn - Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
Federica Sallusto - Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera italiana, Bellinzona, Switzerland
Pere Santamaria - Department of Microbiology, Immunology & Infectious Diseases, University of Calgary, Canada
Alessandro Sette - Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, USA
Craig Slingluff - University of Virginia School of Medicine, Charlottesville, VA, USA
Ludvig Sollid - Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway (final confirmation pending)
Stefan Stevanović - Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany
Kai Wucherpfennig - Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, USA
We are also happy to announce that we will dedicate the session “Tumor Immunology” to Stefan Stevanović on his 60th birthday to honor his achievements in this field.
|
Venue
The HLA Symposium will take place at the lecture hall NORD 1, which is located at the center of the University Hospital Zürich (Frauenklinikstrasse 26, 8091 Zürich) Please use tram number 6, 9 and 10 to station "ETH/Universitätsspital" and follow the yellow way as indicated. The entrance is signposted and the lecture hall is at the top floor, D. There are a few public parking slots available, but public transport is recommended. |
|
Accomodation
The tourism office Zürich has listed a selection of hotels, which are not too far away from the venue. Please refer to that webpage.
The tourism office Zürich has listed a selection of hotels, which are not too far away from the venue. Please refer to that webpage.
Kindly supported by
|
|
|
|
